These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 813410)

  • 1. [Pre- and postnatal treatment of severe Rh-erythroblastosis (author's transl)].
    Fischer K; Poschmann A; Schultze-Mosgau H
    Z Geburtshilfe Perinatol; 1975 Oct; 179(5):319-30. PubMed ID: 813410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Spectrophotometric analysis of amniotic fluid prenatal diagnosis of fetal erythroblastosis].
    Radzuweit H; Eckert L; Zachäus V; Weigel W
    Zentralbl Gynakol; 1971 Mar; 93(12):380-7. PubMed ID: 4995302
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prenatal blood transfusions for anti-D-erythroblastosis in twin pregnancies (author's transl)].
    Schultze-Mosgau H; Fischer K; Poschmann A; Berle P
    Med Klin; 1974 Jan; 69(3):94-6. PubMed ID: 4206040
    [No Abstract]   [Full Text] [Related]  

  • 4. Laboratory identification of erythroblastosis fetalis.
    Kurtz EM; Pappas AA; Cannon A
    Ann Clin Lab Sci; 1982; 12(5):388-97. PubMed ID: 6814344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prenatal diagnosis and therapy of hemolytic disease of the newborn].
    Fischer K; Poschmann A; Hellwege HH; Kitschke HJ; Carstensen M; Sprotte C; Schreer I
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):167-70. PubMed ID: 4010672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methods for analysis of amniotic fluid for diagnosis of the fetal condition in Rh-incompatibility].
    Neumayer E; Stark KH; Westphal BC; Westphal HJ
    Zentralbl Gynakol; 1973 Aug; 95(31):1068-80. PubMed ID: 4203837
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prenatal diagnosis and therapy of fetal hemolytic disease with Rh incompatibility].
    Kitschke HJ; Poschmann A; Carstensen M; Sprotte C; Fischer K; Schreer I
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):470-2. PubMed ID: 3928428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with the intrauterine transfusion in severe rhesus erythroblastosis.
    Hofmann D; Holländer HJ; Mast H; Quakernack K; Schellong G
    Geburtshilfe Frauenheilkd; 1971 Sep; 31(9):797-814. PubMed ID: 4999762
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative analysis of amniotic fluid bilirubin.
    Amstey MS; Hochberg CJ; Choate JW; Wax SH; Lund CJ
    Obstet Gynecol; 1972 Mar; 39(3):407-10. PubMed ID: 4623063
    [No Abstract]   [Full Text] [Related]  

  • 11. [Postnatal primary therapy of Morbus haemolyticus neonatorum in prematurely born infants, following intra-uterine foetal transfusion (author's transl)].
    Plesse R; Pelz L; Klausch B
    Zentralbl Gynakol; 1980; 102(8):457-62. PubMed ID: 7456904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Rh disease by ratios of bilirubin to albumin and hemopexin to albumin in amniotic fluid.
    Muller-Eberhard U; Bashore R
    N Engl J Med; 1970 May; 282(21):1163-7. PubMed ID: 4985821
    [No Abstract]   [Full Text] [Related]  

  • 13. Management and prevention of erythroblastosis fetalis.
    Frigoletto FD
    Clin Perinatol; 1974 Sep; 1(2):321-30. PubMed ID: 4143390
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of maternal blood for intrauterine transfusions.
    Eyster ME; Queenan JT; Haber JM
    Obstet Gynecol; 1969 Nov; 34(5):636-40. PubMed ID: 4981597
    [No Abstract]   [Full Text] [Related]  

  • 15. A critical review of intrauterine fetal transfusion.
    Palmer A; Gordon RR
    Br J Obstet Gynaecol; 1976 Sep; 83(9):688-93. PubMed ID: 823957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Haemolytic disease of the newborn (fetus) (author's transl)].
    Fischer K; Poschmann A
    Immun Infekt; 1976 Dec; 4(6):249-60. PubMed ID: 828142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of different methods of amniotic fluid analysis in the diagnosis of Rh hemolytic disease (spectrophotometric and chemical determination of bilirubin, bilirubin-protein ratio, anti-Rho(D) titres).
    Dambrosio F; Della Torre L; Meroni P; Clerici-Bagozzi D
    Ann Ostet Ginecol Med Perinat; 1970 Aug-1971 Aug; 92(8):528-31. PubMed ID: 5001775
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rhesus erythroblastosis, monitoring and treatment].
    Siebers JW; Rasenack R; Hillemanns HG
    Zentralbl Gynakol; 1985; 107(20):1226-42. PubMed ID: 3934880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spectrophotometric characteristics of the amniotic fluid in Rh isoimmunization following intrauterine fetal blood transfusions].
    Matrova TS; Vasileva Iu
    Akush Ginekol (Sofiia); 1989; 28(1):30-2. PubMed ID: 2500862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with intrauterine transfusions for severe Rh alloimmunization in a developing country.
    Gupte SC; Lulla CP; Kulkarni SS; Korgaonkar SA; Walvekar VR; Merchant RH
    J Matern Fetal Med; 1998; 7(6):287-91. PubMed ID: 9848694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.